CLU and Alzheimer disease: Clusterin can readily cross the BBB, has been shown to sequester Aβ40 and prevent Aβ42 aggregation [14, 48–50]; the inverse correlation with plasma Aβ we identified may thus reflect ongoing changes in the AD brain.